tiprankstipranks
Gossamer Bio appoints Bob Smith as Chief Commercial Officer
PremiumThe FlyGossamer Bio appoints Bob Smith as Chief Commercial Officer
4M ago
Gossamer Bio price target lowered to 50c from $1.50 at Barclays
PremiumThe Fly
Gossamer Bio price target lowered to 50c from $1.50 at Barclays
5M ago
Gossamer Bio reports Q3 EPS (21c), consensus (26c)
PremiumThe Fly
Gossamer Bio reports Q3 EPS (21c), consensus (26c)
5M ago
Gossamer Bio files to sell 162.34M shares of common stock for holders
PremiumThe FlyGossamer Bio files to sell 162.34M shares of common stock for holders
8M ago
Gossamer Bio reports Q2 EPS (45c), consensus (49c)
PremiumThe Fly
Gossamer Bio reports Q2 EPS (45c), consensus (49c)
8M ago
Gossamer Bio downgraded to Neutral from Buy at UBS
PremiumThe Fly
Gossamer Bio downgraded to Neutral from Buy at UBS
9M ago
Gossamer Bio CEO buys $1.0M in common stock
PremiumThe FlyGossamer Bio CEO buys $1.0M in common stock
1y ago
Gossamer Bio price target lowered to $1.50 from $2 at Barclays
PremiumThe Fly
Gossamer Bio price target lowered to $1.50 from $2 at Barclays
1y ago
Gossamer Bio options imply 16.5% move in share price post-earnings
PremiumThe Fly
Gossamer Bio options imply 16.5% move in share price post-earnings
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100